PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: wuw7@cdc.gov.\', \'Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.\', \'Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.\', \'Acute Disease Epidemiology Section, Georgia Department of Public Health, Atlanta, GA.\', \'Division of Renal Medicine, Department of Medicine, Emory School of Medicine, Atlanta, GA.\', \'Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA; Division of Renal Medicine, Department of Medicine, Emory School of Medicine, Atlanta, GA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0196-6553(21)00517-410.1016/j.ajic.2021.07.022
?:doi
?:hasPublicationType
?:journal
  • American journal of infection control
is ?:pmid of
?:pmid
?:pmid
  • 34375701
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.062
?:rankingScore_hIndex
  • 93
?:title
  • Absence of SARS-CoV-2 infections among patients with end-stage renal disease following facility-wide testing in four outpatient hemodialysis facilities.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all